Here at the Janssen Health Policy Centre
our mission is to raise awareness on issues impacting healthcare policy, build
consensus through dialogue, and shape recommendations for future policies

Report-16/09/2015
Prostate Cancer: Living, not Just Surviving

The Prostate Cancer: Living, not Just Surviving report, developed by Janssen EMEA in collaboration with several European prostate cancer patient associations, highlights findings from a pan-European survey of prostate cancer patients, caregivers and healthcare professionals.

download
Report-02/10/2014
FT Health: Combating Cancer

Cancer is the leading cause of death worldwide. The WHO expects that annual cancer cases will increase from 14 million in 2012 to 22 million within the next two decades.

download
Report-30/05/2014
Access to High-quality Oncology Care

A framework for sustainable health system reform The new “Access to high-quality oncology care across Europe” report reveals significant inequalities in access to cancer care across Europe. Published today, the report encompasses the full patient pathway, from prevention to treatment. Commissioned by Janssen Pharmaceutica NV and independently researched by The Swedish Institute of Health Economics (IHE), the report provides recommendations for breaking down barriers and improving access to quality cancer care.

download

Prostate Cancer: Living, not Just Surviving

The Prostate Cancer: Living, not Just Surviving report, developed by Janssen EMEA in collaboration with several European prostate cancer patient associations, highlights findings from a pan-European survey of prostate cancer patients, caregivers and healthcare professionals.

The report calls for a greater focus on addressing the quality of life needs of men living with prostate cancer in Europe.The report reveals insights into the emotional, social and physical issues faced by prostate cancer patients, their caregivers and their families and aims to raise awareness of the need to improve quality of life for those affected by the disease.

Download the report

Read the e-book

FT Health: Combating Cancer

Cancer is the leading cause of death worldwide and these are on the rise. The World Health Organisation expects that annual cancer cases will increase from 14 million in 2012 to 22 million within the next two decades.[i] However, whilst growing research and innovation in cancer prevention, diagnosis and treatment is helping improve prospects for patients globally, challenges still exist, for example, in access to the right resources. A Financial Times (FT) special report, published on 26th September 2014, gives a global overview of the current key issues around this ever increasing health concern.

i World Health Organisation. Cancer – key facts.

Download FT Health Combating Cancer special report

“This document is not authored by Janssen, and was made possible through an unconditional sponsorship from Janssen whereby the authors had full editorial input and control. This document reflects the opinions and views of the authors, and are not necessarily those of Janssen.”

Download the report

 

Access to high-quality oncology care across Europe

A framework for sustainable health system reform

The new “Access to high-quality oncology care across Europe” report reveals significant inequalities in access to cancer care across Europe. Published today, the report encompasses the full patient pathway, from prevention to treatment. Commissioned by Janssen Pharmaceutica NV and independently researched by The Swedish Institute of Health Economics (IHE), the report provides recommendations for breaking down barriers and improving access to quality cancer care. 

Download the Access to high-quality oncology care across Europe report

Download the report

Download the infographic

 

Watch the video below, with the Company Group Chairman of Janssen EMEA, Jane Griffiths, about access to high-quality oncology care across Europe.

Need for long-term view to improve cancer care

The report reveals that, for some cancer types, there is a shift underway from treating what was once a deadly disease to managing a chronic illness. In light of this, patient outcome measures such as quality of life and productivity become more important – both because of what it means for the patient and for the economy in these times of austerity. The report cited advances in treatment and the availability of high-quality cancer care as key drivers for improved survival rates and better patient outcomes over the long-term. 

The report provides recommendations in six key areas for breaking down barriers and improving access to quality cancer care. 

More about “Access to high-quality oncology care across Europe”

Report archive